SHAZIA JOSEPH: Open Payments
NPI 1336703586 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,484 in 93 payments from 15 companies in 2025. Trend: 2023 $1,525 · 2024 $2,683 · 2025 $3,484
Food & beverage: $3,484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $1,792 |
| GlaxoSmithKline, LLC. | 12 | $326 |
| ABBVIE INC. | 13 | $307 |
| Indivior Inc. | 11 | $202 |
| Phathom Pharmaceuticals, Inc. | 2 | $152 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $144 |
| GENZYME CORPORATION | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Braeburn Inc. | 4 | $103 |
| Novo Nordisk Inc | 2 | $62 |
Products named: BREZTRI, FARXIGA, VRAYLAR, FASENRA, AIRSUPRA, TRELEGY ELLIPTA, SUBLOCADE, VOQUEZNA.
Industry payments across CT — which companies pay providers there.
